Inosine reduces ischemic brain injury in rats

Stroke

Volumn 36, Issue 3, 2005, Pages 654-659

  Shen, Hui ^a   Chen, Guann Juh ^a   Harvey, Brandon K ^a,b   Bickford, Paula C ^a,b   Wang, Yun ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Inosine, adenosine; Neuroprotection; Stroke

Indexed keywords

1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; HYPOXANTHINE; INOSINE; TRIPHENYLTETRAZOLIUM;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCOMOTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PARIETAL LOBE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; HYPOXANTHINES; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; INOSINE; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 14844322835     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000155747.15679.04     Document Type: Article

References (22)

1. Shi M, You SW, Meng JH, Ju G. Direct protection of inosine on PC12 cells against zinc-induced injury. NeuroReport. 2002;13:477-479.
2. Haun SE, Segeleon JE, Trapp VL, Clotz MA, Horrocks LA. Inosine mediates the protective effect of adenosine in rat astrocyte cultures subjected to combined glucose-oxygen deprivation. J Neurochem. 1996; 67:2051-2059.
3. Litsky ML, Hohl CM, Lucas JH, Jurkowitz MS. Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res. 1999;821:426-432.
4. Goldhaber SZ, Pohost GM, Kloner RA, Andrews E, Newell JB, Ingwall JS. Inosine: a protective agent in an organ culture model of myocardial ischemia. Circ Res. 1982;51:181-188.
5. Matsumoto K, Graf R, Rosner G, Taguchi J, Heiss WD. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab. 1993;13:586-594.
6. Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI. Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci USA. 2002;99:9031-9036.
7. Fujimori H, Yasuda M, Pan-Hou H. Enhancement of cellular adenosine triphosphate levels in PC12 cells by extracellular adenosine. Biol Pharm Bull. 2002;25:307-311.
8. Macek TA, Schaffhauser H, Conn PJ. Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J Neurosci. 1998;18:6138-6146.
9. Ortinau S, Laube B, Zimmermann H. ATP inhibits NMDA receptors after heterologous expression and in cultured hippocampal neurons and attenuates NMDA-mediated neurotoxicity. J Neurosci. 2003;23: 4996-5003.
10. Ferreira JM, Paes-de-Carvalho R. Long-term activation of adenosine A(2a) receptors blocks glutamate excitotoxicity in cultures of avian retinal neurons. Brain Res. 2001;900:169-176.
11. Kaku T. Hada J, Hayashi Y. Endogenous adenosine exerts inhibitory effects upon the development of spreading depression and glutamate release induced by microdialysis with high K+ in rat hippocampus. Brain Res. 1994;658:39-48.
12. Wang Y, Chang CF, Morales M, Chiang YH, Su TP, Tsao LI, Thiemermann C. Neuroprotective effects of diadenosine teraphosphate in animal models of stroke and Parkinson's disease. J Neurosci. 2003;23: 7958-7965.
13. Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW. Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci. 2003;6:743-749.
14. Melani A, Pantoni L, Corsi C, Bianchi L, Monopoli A, Bertorelli R, Pepeu G, Pedata F. Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage. Stroke. 1999;30:2448-2454.
15. Jacobson KA, Park KS, Jiang JL, Kim YC, Olah ME, Stiles GL, Ji XD. Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology. 1997;36:1157-1165.
16. Jin X, Shepherd RK, Duling BR, Linden J. Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest. 1997;100: 2849-2857.
17. Gomez G, Sitkovsky MV. Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood. 2003;102:4472-4478.
18. Von Lubitz DK, Simpson KL, Lin RC. Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci. 2001;939:85-96.
19. Van Schaick EA, Jacobson KA, Kim HO, IJzerman AP, Danhof M. Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-C1-IB-MECA in conscious rats. Eur J Pharmacol. 1996;308:311-314.
20. Fedorova IM, Jacobson MA, Basile A, Jacobson KA. Behavioral characterization of mice lacking the A3 adenosine receptor: sensitivity to hypoxic neurodegeneration. Cell Mol Neurobiol. 2003;23:431-447.
21. Popoli P, Frank C, Tebano MT, Potenza RL, Pintor A, Domenici MR, Nazzicone V, Pezzola A, Reggio R. Modulation of glutamate release and excitotoxicity by adenosine A2A receptors. Neurology. 2003;61: S69-S71.
22. Brand A, Vissiennon Z, Eschke D, Nieber K. Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology. 2001;40:85-95.